title: Implementation of an osteoporosis research program with a mobile dual-energy X-ray absorptiometry unit: the Montana/Wyoming experience.
abstract: To expedite recruitment, and subject participation, for a large clinical osteoporosis therapy trial utilizing the bisphosphonate ibandronate, an integrated network of 13 satellite clinical sites was developed, linked by a mobile clinic vehicle transporting a dual-energy X-ray absorptiometry (DXA) unit. A predominantly rural area of the United States (Montana, northern Wyoming) was accessed for the project, due to the large pool of potential subjects living in this area who were not yet involved in osteoporosis clinical studies. The results of the project to date (through 10 months) confirm the feasibility of such a study design, with 1774 subjects screened by DXA for the study, and 280 (15.8%) accepted. The mobile DXA unit has functioned according to specifications for a stationary DXA machine, with the stability of spine phantom measurements over 10 months assessed as a coefficient of variation of 0.46%. The success of the project validates the concept of performing clinical osteoporosis therapy trials in previously underutilized rural community settings, facilitated by a satellite site network and mobile clinic.
authors.affiliation: Osteoporosis Research Group, University of Washington, Seattle, USA.
authors.forename: U
authors.initials: U
authors.lastname: Ulrich
authors.forename: M
authors.initials: M
authors.lastname: Browning
authors.forename: E V
authors.initials: EV
authors.lastname: Gaffney
authors.forename: K H
authors.initials: KH
authors.lastname: Schöter
authors.forename: C H
authors.initials: CH
authors.lastname: Chesnut
mesh_terms: D015502:Absorptiometry, Photon / Q000295:instrumentation*; D000368:Aged; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use*; D004867:Equipment Design; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D000077557:Ibandronic Acid; D008297:Male; D008875:Middle Aged; D008952:Mobile Health Units; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D018579:Patient Selection; D015397:Program Evaluation; D012424:Rural Population
chemical_list: D004164:Diphosphonates; D000077557:Ibandronic Acid